What are spherocytes and poikilocytosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Spherocytes and Poikilocytosis: Definitions and Clinical Significance

Spherocytes are abnormally round red blood cells that have lost their normal biconcave disc shape and central pallor, while poikilocytosis is the general term for the presence of abnormally shaped red blood cells of various types on a blood smear.

Understanding Spherocytes

Spherocytes are a specific type of poikilocyte characterized by:

  • Loss of central pallor due to their spherical rather than biconcave shape
  • Reduced surface area-to-volume ratio, making them less deformable
  • Decreased flexibility and mechanical stability, leading to premature destruction in the spleen

These cells are classically associated with hereditary spherocytosis, a red cell membrane disorder caused by defects in membrane skeletal proteins (particularly spectrin) that result in loss of membrane cohesion and progressive surface area loss 1. The spherocytes lack the strength, durability, and flexibility to withstand circulatory stresses, leading to hemolytic anemia 2.

Understanding Poikilocytosis

Poikilocytosis is a broader descriptive term encompassing any variation in red blood cell shape. While occasional nonspecific poikilocytes appear in normal blood smears, dominance of one or more specific poikilocyte forms usually indicates a specific anemia or organ system disease 3.

Common Types of Poikilocytes Include:

Round forms:

  • Spherocytes (membrane disorders)
  • Stomatocytes (acute alcoholism, liver disease)
  • Target cells (liver disease, hemoglobinopathies)

Elongated forms:

  • Elliptocytes/ovalocytes (hereditary elliptocytosis)
  • Dacryocytes/teardrop cells (myelofibrosis, "spent" polycythemia vera)
  • Sickle cells (sickle cell disease)

Fragmented forms:

  • Schistocytes (microangiopathic hemolytic anemia)
  • Echinocytes/burr cells (uremia, liver disease)
  • Acanthocytes/spur cells (severe liver disease, abetalipoproteinemia)

Clinical Context and Diagnostic Pitfalls

Critical distinction: In contrast to membrane disorders where spherocytes predominate, conditions like pyruvate kinase (PK) deficiency typically show unremarkable red cell morphology with only nonspecific anisocytosis and poikilocytosis 4. This is a key diagnostic pitfall—the absence of prominent spherocytes does NOT exclude hemolytic anemia.

Important Clinical Associations:

Poikilocytosis with specific disease states:

  • Gastrointestinal parasitism, chronic diarrhea, hepatic and renal disease are significantly associated with moderate-to-marked poikilocytosis, often reflecting iron deficiency from chronic blood loss or iron-restricted erythropoiesis 5
  • Spiculated cells (echinocytes, acanthocytes) appear more frequently with hepatic and renal disease 5
  • Post-splenectomy: Echinocytes may comprise 3-30% of cells in conditions like PK deficiency 4

Age-Related Considerations:

Poikilocytosis is more prevalent in young animals and children, with elliptocytes, dacryocytes, and schistocytes predominating in younger individuals 5. This physiologic variation should not be mistaken for pathology.

Diagnostic Approach

When evaluating poikilocytosis:

  1. Identify the predominant poikilocyte type—this narrows the differential diagnosis significantly
  2. Correlate with hemolysis markers (reticulocyte count, LDH, haptoglobin, bilirubin)
  3. Consider membrane disorders when spherocytes dominate
  4. Consider enzyme deficiencies when hemolysis exists but morphology is relatively unremarkable
  5. Evaluate for iron deficiency when moderate-to-marked poikilocytosis is present, particularly with chronic disease 5

The presence of spherocytes specifically should prompt evaluation for hereditary spherocytosis through osmotic fragility testing, flow cytometry, ektacytometry, or genetic testing 1, while nonspecific poikilocytosis requires systematic exclusion of immune-mediated hemolysis, membrane defects, unstable hemoglobins, and metabolic disorders 4.

Related Questions

What does the presence of atypical lymphocytes, burr (echinocyte) cells, and ovalocytes on a peripheral blood smear suggest, and what initial work‑up should be done?
What does a blood test film comment indicating polychromasia, anisochromasia, and a few poikilocytes (irregularly shaped red blood cells) mean?
How should hereditary spherocytosis be treated in adult patients?
What is the most likely cause and appropriate diagnostic work‑up for a peripheral blood smear showing mildly hypochromic red blood cells with anisopoikilocytosis, including microcytes, elliptocytes, and occasional dacrocytes?
What does anisocytosis indicate, and what is the recommended work‑up and treatment approach?
How should I interpret INR results and adjust warfarin dosing for different indications (e.g., atrial fibrillation, deep‑vein thrombosis, pulmonary embolism, mechanical aortic valve, mechanical mitral valve)?
What are microcytosis, polychromasia, and spherocytes?
What is a sports hernia (athletic pubalgia)?
When should casting be initiated for a comminuted intra-articular distal radius fracture, and how long should the cast be maintained?
What is the differential diagnosis for a 14-year-old male who experiences elbow locking when the joint is held in flexion for a prolonged period?
In a 53‑year‑old man with combined systolic‑diastolic heart failure, persistent erythrocytosis (hemoglobin 18.3 g/dL, hematocrit 54 %, RBC 5.97 ×10^12/L), history of pulmonary sarcoidosis in remission, normal cardiac imaging and electrophysiology, and a benign 0.62‑mm gallbladder polyp, how should I proceed with management given that the hematologist declined to treat the erythrocytosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.